Indications and Purposes
| 1 Indications And Usage Xermelo Is Indicated For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog (Ssa) Therapy In Adults Inadequately Controlled By Ssa Therapy. Xermelo Is A Tryptophan Hydroxylase Inhibitor Indicated For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog (Ssa) Therapy In Adults Inadequately Controlled By Ssa Therapy. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Telotristat Ethyl |